|
ORMDL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.531600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.171200E-01 |
| Normal-vs-Stage2 |
3.952400E-02 |
| Normal-vs-Stage3 |
1.218580E-01 |
| Normal-vs-Stage4 |
1.180750E-01 |
| Stage1-vs-Stage2 |
1.591980E-01 |
| Stage1-vs-Stage3 |
5.316600E-01 |
| Stage1-vs-Stage4 |
5.067800E-01 |
| Stage2-vs-Stage3 |
3.903600E-01 |
| Stage2-vs-Stage4 |
3.740400E-01 |
| Stage3-vs-Stage4 |
9.894800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.999620E-01 |
| Normal-vs-AfricanAmerican |
7.515300000005E-05 |
| Normal-vs-Asian |
5.679500E-03 |
| Caucasian-vs-AfricanAmerican |
4.222500E-04 |
| Caucasian-vs-Asian |
3.594100E-02 |
| AfricanAmerican-vs-Asian |
4.802800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.359800E-01 |
| Normal-vs-Female |
2.181200E-03 |
| Male-vs-Female |
2.282300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.938600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.750100E-02 |
| Normal-vs-Age(61-80Yrs) |
7.859500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.691400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.440400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.498830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.001200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.874400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.763600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.350600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.301600E-02 |
| Normal-vs-Grade 2 |
2.288000E-02 |
| Normal-vs-Grade 3 |
3.440000E-01 |
| Normal-vs-Grade 4 |
1.599600E-01 |
| Grade 1-vs-Grade 2 |
6.599800E-01 |
| Grade 1-vs-Grade 3 |
1.761230E-01 |
| Grade 1-vs-Grade 4 |
4.337800E-01 |
| Grade 2-vs-Grade 3 |
6.913600E-02 |
| Grade 2-vs-Grade 4 |
6.046800E-01 |
| Grade 3-vs-Grade 4 |
3.965400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.614000E-02 |
| Normal-vs-ccB subtype |
3.545600E-01 |
| ccA subtype-vs-ccB subtype |
2.834600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.086100E-02 |
| Normal-vs-N1 |
6.961400E-01 |
| N0-vs-N1 |
6.102400E-01 |
|
|
